Lesaka Technologies Schedules Special Shareholder Meeting for June 3, 2024

TL;DR

**Lesaka Technologies will hold a special shareholder meeting on June 3, 2024, to vote on a stock option grant for its Executive Chairman and an increase in authorized shares.**

AI Summary

LESAKA TECHNOLOGIES INC (LSAK) filed a Proxy Statement (DEF 14A) with the SEC on April 22, 2024. A Special Meeting of Shareholders for Lesaka Technologies, Inc. is scheduled for June 3, 2024. The meeting will be held at the company's principal executive offices in Johannesburg, South Africa. Shareholders will vote on approving a stock option grant for Executive Chairman Ali Mazanderani. The agenda also includes approving an amendment to the Stock Incentive Plan to increase authorized shares by 3,000,000. April 8, 2024, was set as the record date for determining shareholder eligibility to vote.

Why It Matters

For investors and stakeholders tracking LESAKA TECHNOLOGIES INC, this filing contains several important signals. The meeting's primary purpose is to seek shareholder approval for executive compensation and equity dilution, which could impact existing shareholders' ownership percentage. Shareholder approval is required by Nasdaq Listing Rule 5635(c) for the stock option grant, indicating a compliance-driven event.

Risk Assessment

Risk Level: LSAK — LESAKA TECHNOLOGIES INC shows moderate risk based on this filing. The filing is a routine proxy statement for a shareholder meeting, with no immediate financial or operational concerns highlighted.

Analyst Insight

Shareholders should review the proxy materials carefully to understand the implications of the proposed stock option grant and the increase in authorized shares before the June 3, 2024 meeting.

Financial Highlights

debt To Equity

N/A

revenue

N/A

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

N/A

eps

N/A

gross Margin

N/A

cash Position

N/A

revenue Growth

N/A

Executive Compensation

Key Numbers

• June 3, 2024 — Meeting Date (Special Meeting of Shareholders)
• April 8, 2024 — Record Date (Shareholder eligibility for meeting)
• 3,000,000 — Authorized Shares Increase (Stock Incentive Plan amendment)
• 27 11 343 2000 — Business Phone (Company contact information)

Key Players & Entities

• Lesaka Technologies, Inc. (company) — Registrant
• Ali Mazanderani (person) — Executive Chairman
• Nasdaq (company) — Listing Rule Compliance
• Kuben Pillay (person) — Lead Independent Director
• June 3, 2024 (date) — Meeting Date
• April 8, 2024 (date) — Record Date
• 20240422 (date) — Filing Date
• 0001062993-24-008640 (document) — Accession Number

FAQ

Risk Factors

• Compliance with Nasdaq Listing Rules [low — regulatory]: The company is seeking shareholder approval for a stock option grant to comply with Nasdaq Listing Rule 5635(c).
• Equity Dilution [medium — financial]: An amendment to the Stock Incentive Plan proposes to increase the number of authorized shares by 3,000,000, potentially diluting existing shareholders' ownership.

Industry Context

Lesaka Technologies, Inc. operates in the financial services sector, providing technology solutions. This filing is a standard proxy statement for a publicly traded company.

Regulatory Implications

The company is subject to SEC regulations regarding proxy solicitations and shareholder voting, including Nasdaq listing rules for equity grants.

What Investors Should Do

1. Review the full proxy statement for details on the stock option grant and equity plan amendment.
2. Assess the potential impact of the 3,000,000 share increase on existing shareholder equity.
3. Vote on the proposed resolutions at the June 3, 2024 shareholder meeting.

Key Dates

• 2024-06-03: Special Meeting of Shareholders — To approve stock option grant and equity plan amendment.
• 2024-04-08: Record Date — Determines shareholders eligible to vote.
• 2024-04-22: Filing Date — Date the DEF 14A proxy statement was filed.

Glossary

DEF 14A

Definitive Proxy Statement filed with the SEC. (Provides detailed information about matters to be voted on at a shareholder meeting.)

Stock Option Agreement

An agreement granting the holder the right to purchase company stock at a specified price. (Key item for shareholder vote, impacting executive compensation and potential equity dilution.)

Stock Incentive Plan

A plan that allows a company to grant equity-based compensation to employees and executives. (The amendment seeks to increase the number of shares available for issuance under the plan.)

Year-Over-Year Comparison

This is a DEF 14A filing, which is a definitive proxy statement. Previous filings may include annual reports (10-K) or other periodic disclosures, but this specific filing type relates to upcoming shareholder votes.

Key Financial Figures

• $6.00 — stock options at an exercise price of US$6.00 per share; 1,000,000 stock options at a
• $8.00 — stock options at an exercise price of US$8.00 per share; 1,000,000 stock options at a
• $11.00 — stock options at an exercise price of US$11.00 per share; 1,000,000 stock options at a
• $14.00 — stock options at an exercise price of US$14.00 per share. Exercise Date Mr. Mazande
• $3.50 — 500,000 shares at an exercise price of $3.50 per share that vests on the one-year an
• $1,000,000 — compensation for that executive exceeds $1,000,000 in any taxable year. Under Section 162(

Filing Documents

• formdef14a.htm (DEF 14A) — 194KB
• formdef14ax001.jpg (GRAPHIC) — 3KB
• formdef14ax002.jpg (GRAPHIC) — 3KB
• formdef14axu001.jpg (GRAPHIC) — 87KB
• formdef14axu002.jpg (GRAPHIC) — 98KB
• formdef14axu003.jpg (GRAPHIC) — 90KB
• formdef14axu004.jpg (GRAPHIC) — 161KB
• 0001062993-24-008640.txt ( ) — 804KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 13 ADDITIONAL INFORMATION 15 APPENDIX A - OPTION AWARD AGREEMENT APPENDIX B - PLAN AMENDMENT 1 LESAKA TECHNOLOGIES, INC. VOTING RIGHTS AND PROCEDURES Shareholders as of the close of business on April 8, 2024, the record date, may attend and vote at the meeting. Each share is entitled to one vote. There were 62,343,444 shares of common stock outstanding on the record date. We anticipate that this proxy statement and the form of proxy relating to our meeting will be mailed to our shareholders commencing on or about April 22, 2024. A majority of the total number of outstanding shares of common stock, present either in person or by proxy, will constitute a quorum for the transaction of business at the meeting. Shareholders who are present at the meeting in person or by proxy and who abstain will be treated as present for purposes of determining whether a quorum is present. In the event that there are not sufficient votes to approve any proposal at the meeting, the meeting may be adjourned in order to permit the further solicitation of proxies. The inspector of election appointed for the meeting will tabulate all votes and will separately tabulate affirmative and negative votes and abstentions. The meeting shareholders will be asked to vote on the following proposal: Proposal No. 1 - The Stock Option Agreement Proposal will be approved if the votes cast in favor of the proposal exceed the number of votes cast against the proposal. You may vote for or against the proposal or you may abstain from voting. Abstentions and broker non-votes will not affect the outcome of the vote. Proposal No. 2 - The amendment of our current Amended and Restated Stock Incentive Plan to increase the number of shares authorized for issuance thereunder will be approved if the votes cast in favor of the proposal exceed the number of votes cast against the proposal. You may vote for or against the proposal or you ma

View Full Filing

View this DEF 14A filing on SEC EDGAR